Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 16386106)

Published in AIDS Res Hum Retroviruses on November 01, 2005

Authors

E Ramayo1, M P González-Moreno, J Macías, M Cruz-Ruíz, J A Mira, A M Villar-Rueda, J A García-García, J M Gómez-Mateos, F Lozano, J A Pineda

Author Affiliations

1: Unidad de Enfermedades Infecciosas, Servicio de Análisis Clínicos, Hospital Universitario de Valme, 41014-Seville, Spain.

Articles by these authors

[Prevalence of antibodies against hepatitis C virus in a sample of homosexual males]. Med Clin (Barc) (1993) 1.94

CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood (1998) 1.91

Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J Cell Biol (1997) 1.84

Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother (2000) 1.51

Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J (2010) 1.50

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43

Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood (2000) 1.35

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut (2005) 1.28

Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials (2003) 1.18

Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol (1998) 1.17

Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS (1992) 1.15

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS (1998) 1.14

Diagnosis of infections with Leishmania infantum using PCR-ELISA. Parasitology (2001) 1.12

CD43 monoclonal antibodies recognize the large sialoglycoprotein of human leukocytes. Eur J Immunol (1987) 1.12

Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis (2008) 1.05

Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol (1992) 1.03

High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg (1999) 1.03

Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog Brain Res (1991) 1.03

Concentrations of cefmetazole in plasma and tissue resulting from peri-incisional administration before appendectomy. Antimicrob Agents Chemother (1984) 1.02

CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol (2000) 0.99

Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis (1996) 0.98

Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol (1997) 0.97

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2002) 0.96

Outbreak of Brucella melitensis among microbiology laboratory workers. J Clin Microbiol (1994) 0.95

Transient immunologic defect in a case of Listeria rhombencephalitis. Arch Neurol (1987) 0.95

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2010) 0.95

The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum. Ann Trop Med Parasitol (2002) 0.94

Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol (1993) 0.93

The role of the left inferior frontal gyrus in social perception: an rTMS study. Brain Res (2011) 0.93

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis (2003) 0.93

Fatal Psychrobacter immobilis infection in a patient with AIDS. AIDS (1994) 0.92

Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur J Immunol (1999) 0.92

Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis. J Antimicrob Chemother (2008) 0.92

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Med (2011) 0.92

Expression of the innate defense receptor S5D-SRCRB in the urogenital tract. Tissue Antigens (2014) 0.92

Biochemical characterization of recombinant and circulating human Spalpha. Tissue Antigens (2004) 0.91

The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study. J Clin Pathol (2001) 0.91

Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J Immunol (1998) 0.90

Leptospira abortion in horses. J Vet Diagn Invest (1989) 0.90

Is hepatitis G virus transmitted sexually? JAMA (1997) 0.89

Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol (1998) 0.89

Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts. Eur J Clin Microbiol Infect Dis (2001) 0.89

Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis (1998) 0.89

Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat (2009) 0.88

Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur J Immunol (1991) 0.88

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med (2011) 0.88

Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J Am Acad Dermatol (1988) 0.88

Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet (1988) 0.87

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2006) 0.86

High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease. Clin Microbiol Infect (2014) 0.86

Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Trop Med Hyg (1996) 0.86

Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996. AIDS (1997) 0.86

Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes. J Immunol (1991) 0.86

Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2006) 0.86

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis (2001) 0.85

[Erosive gastritis associated with cryptosporidium in 2 patients with AIDS]. Acta Gastroenterol Latinoam (1994) 0.85

Cervical lipomatosis in HIV-infected patients: a case-control study. HIV Med (2007) 0.85

Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis (1999) 0.85

The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and -independent diacylglycerol production. J Immunol (1997) 0.85

Isolated renal mucormycosis in two AIDS patients. Eur J Clin Microbiol Infect Dis (1994) 0.84

Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy. HIV Med (2004) 0.84

Association of an activation inducible serine kinase activity with CD5. J Immunol (1993) 0.84

Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain. Eur J Clin Microbiol Infect Dis (2001) 0.84

High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome. Rheumatology (Oxford) (2001) 0.84

Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis (1993) 0.84

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice. HIV Med (2010) 0.84

Leishmania spp infection in injecting drug users. Lancet (2002) 0.83

Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells. Eur J Immunol (1992) 0.83